H
Hammoudi-Triki D., Ferquel E., Robbe-Vincent A., Bon
C., Choumet V. & LarabaDjebari F. (2004). Epidemiological data,
clinical admission gradation and biological quantification by ELISA of scorpion
envenomations in Algeria: effect of immunotherapy. Trans R Soc Trop Med
Hyg, 98, (4), 240-50.
Hminou R., Soulaymani A., Mokhtari A., Arfaoui A., El
oufir G., Semlali I., Soulaymani Bencheikh R. (2008). Risk factors
caused by scorpion stings and envenomations in the province of kelâa des
sraghna (Morocco). J. Venom. Anim.Toxins incl. Trop.Dis, 14, (4), 628-
640.
Hubel K. A. (1983).Effects of scorpion venom on
electrolyte transport by rabbit ileum. Am J Physiol Gastrointest Liver
Physiol, 244, (5), 501-506.
Hutt M. J. & Houghton P.J.(1998). A survey
from the literature of plants used to treat scorpion stings. Ethno-
pharmacology, 60, 97-110.
I
Inceoglu B., Lango J., Jing J.,Chen L., Doymaz F.,
Pessah I. & Hammock B.D. (2003). One scorpion, two venoms:
Prevenom of Parbuthus transvaalicus acts as an alternative type of venom with
distinct mechanism of action. PNAS, 100, (3), 922-927.
Ismail M., Shibi A. & Abdullah M. (1983).
Pharmaco kinetics of I125 labeled antivenin to the venom from the
scorpion Androctonus amoreuxi? Toxicon , 1, 47-56.
Ismail M. (1994). The traitement of the
scorpion enveniming syndroms: the Saudi expérience with
sérothérapy . Toxicon, 32, (9), 1019-1024.
Ismail M. & Abd-Elsalam M.A. (1996).
Serotherapy of scorpion envenoming: pharmacokinetics of antivenoms and a
critical assessment of their usefulness. Toxicon, 34, (2), 147-147.
Ismail M. (2003). Treatment of the scorpion
envenoming syndrome: 12 years experience with serotherapy. International
Journal ofAntimicrobial Agents, 21, (2), 170-174.
J
Jarrar BM & Al-Rowaily MA.
(2008).Epidemiological aspects of scorpion stings in Al-Jouf Province, Saudi
Arabia. Ann Saudi Med.,28, (3),183-7.
Jiménez E., Reynosa I., Perez Y. &
Tortoriello J. (2005). The secretagogue effect of the poison from
Centruroides limpidus limpidus on the pancreas of mice and the antagonistic
action of the bouvardia ternifolia extract. Phytomedicine, 12, 65,
71.
Jungo F. & Bairoch A. (2005). Tox-Prot, the
toxin protein annotation program of the SwissProt protein knowledgebase.
Toxicon, 45, 293-301.
K
Karnad D.R. (1998). Haemodynamic patterns in
patients with scorpion envenomation. Heart,79, 485- 489.
Karren J. B. (2001). Scorpions. Extension
Entomology, n°68.
Krifi M. N., Kharrat H, Zghal K., Abdouli M., Abroug
F., Bouchoucha S., Dellagi K. & El Ayeb M. (1998). Development of
an ELISA for the detection of scorpion venoms in sera of humans envenomed by
Androctonus australis garzonii (AAG) and Buthus occitanus tunetanus (BOT):
correlation with clinical severity of envenoming in Tunisia. Toxicon,
36, (6), 887-900.
Krifi N., Kharrat H. & El ayab M. (1999).
Evaluation of antivenom therapy in children severely envenomed by Androctonus
australis garzonii (Aag) and Buthus occitanus tunetanus (Bot) scorpions.
Toxicon, 37, (11), 1627-1634.
Krifi M.N., Savin S., Debray M., Bon C., El Ayeb M.
& Choumet V. (2005). Pharmacokinetic studies of scorpion venom
before and after antivenom immunotherapy. Toxicon, 45, 187-198.
Krishna Murthy k. R. (2000). The scorpion
envenoming syndrome: a different perspective. The physiological basis of the
role of insulin in scorpion envenoming. J. Venom. Anim.
Toxins, 6, (1), 4-51.
Krishna Murthy k. R. & Zare M. A.
(2002). Scorpion antivenom reverses metabolic, electrocardiographic,
and hormonal disturbances caused by the Indian red scorpion mesobuthus tamulus
concanesis, pocock envenomation. Venom. Anim. Toxins, 8, (1), 30-48
Kristal C., Shemesh I.Y., Mishal Y. & Bourvin A.
(1998). Cardiac failure following sting of yellow scorpion in an
adult, Harefuah,134, (6), 452-454.
| 
